Daily pill trial aims to tame hormone disorder, boost health
NCT ID NCT03760835
Summary
This study is comparing a new once-daily pill against standard treatments for adults with congenital adrenal hyperplasia (CAH), a lifelong hormone condition. It aims to see if the new pill, designed to mimic the body's natural cortisol rhythm, can better control the disease and reduce long-term health risks like heart disease and bone loss. Researchers will also check if it improves quality of life, sexual function, and mood for the 150 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Federico II University
RECRUITINGNaples, 80131, Italy
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.